Back
Astrana Health Quote, Financials, Valuation and Earnings
Sponsored
ASTH
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
11
ASTH
Astrana Health
Last Price:
41.9300
Seasonality Move:
25.02%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Astrana Health Price Quote
$41.9300
-1.0000 (-2.33%)
(Updated: November 13, 2024 at 5:55 PM ET)
Astrana Health Key Stats
Sell
11
Astrana Health (ASTH)
is a Sell
Day range:
$42.4800 - $46.7400
52-week range:
$32.0000 - $63.2000
Dividend yield:
0%
P/E ratio:
33.28
P/S ratio:
1.19
P/B ratio:
2.91%
Volume:
590.4K
Avg. volume:
290.2K
1-year change:
42.15%
Market cap:
$2.1B
Revenue:
$1.4B
EPS:
$1.3
How Much Does Astrana Health Make?
-
How Much Are Astrana Health's Sales Annually?
ASTH Revenues are $1.4B -
How Much Profit Does Astrana Health's Make A Year?
ASTH net income is $60.7M
Is Astrana Health Growing As A Company?
-
What Is Astrana Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.37% -
What Is Astrana Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.3%
Astrana Health Stock Price Performance
-
Did Astrana Health Stock Go Up Last Month?
Astrana Health share price went down by -23.65% last month -
Did ASTH's Share Price Rise Over The Last Year?
ASTH share price rose by 42.15% over the past 1 year
What Is Astrana Health 52-Week High & Low?
-
What Is Astrana Health’s 52-Week High Share Price?
Astrana Health has traded as high as $63.2000 over the past 52 weeks -
What Is Astrana Health’s 52-Week Low Share Price?
Astrana Health has traded as low as $32.0000 over the past 52 weeks
Astrana Health Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Astrana Health?
-
How Much Debt Does Astrana Health Have?
Total long term debt quarterly is $438.1M -
How Much Cash Does Astrana Health Have?
Cash and short term investments quarterly total is $350.3M -
What Is Astrana Health’s Book Value Per Share?
Book value per share is 14.75
Is Astrana Health Cash Flow Positive?
-
What Is ASTH Cash Flow From Operations?
Cash flow from operations (TTM) is $63.9M -
What Is Astrana Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is $165.1M -
What Is Astrana Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$197.3M
Astrana Health Return On Invested Capital
-
Is Management Doing A Good Job?
ASTH return on invested capital is 7.4% -
What Is Astrana Health Return On Assets?
ROA measures how assets are converting to revenues and is 5.41% -
What Is ASTH Return On Equity?
ROE is a measure of profitability and is 12.67%
Astrana Health Earnings Date & Stock Price
-
What Is Astrana Health's Stock Price Today?
A single share of ASTH can be purchased today for 42.9300 -
What Is Astrana Health’s Stock Symbol?
Astrana Health trades on the nasdaq under the ticker symbol: ASTH -
When Is Astrana Health’s Next Earnings Date?
The next quarterly earnings date for Astrana Health is scheduled on February 27, 2025 -
When Is ASTH's next ex-dividend date?
Astrana Health's next ex-dividend date is November 14, 2024 -
How To Buy Astrana Health Stock?
You can buy Astrana Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Astrana Health Competitors
-
Who Are Astrana Health's Competitors?
Below is a list of companies who compete with Astrana Health or are related in some way:
Astrana Health Dividend Yield
-
What Is ASTH Dividend Yield?
Astrana Health’s dividend yield currently is 0% -
What Is Astrana Health’s Payout Ratio?
Astrana Health’s payout ratio is 98.8% -
When Did Astrana Health Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Astrana Health’s Dividend Per Share?
Astrana Health pays a dividend of $0.0000 per share
Astrana Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -29.79% | 9.82% |
Revenue: | 37.49% | 3.53% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 64.8750 |
Upside from Last Price: | 51.12% |